Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Brett A. Grimaud files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eli Samaha - $5.91M of TBPH open-market activity in the last 12 months
- Eran Broshy - $1.66M of TBPH open-market activity in the last 12 months
- Rhonda Farnum - $1.23M of TBPH open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Brett A. Grimaud?
Brett A. Grimaud is a corporate insider, tracked as SVP, GEN COUNSEL AND SECRETARY of Theravance Biopharma, Inc. (TBPH). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Brett A. Grimaud submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Brett A. Grimaud's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Brett A. Grimaud and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
